Clinical trial
Clinical and Pharmacokinetic Trial of Intra-Abdominal Irinotecan
NCT00183859 · University of Southern California, Other · Completed
Key facts
| NCT number | NCT00183859 |
|---|---|
| Title | Clinical and Pharmacokinetic Trial of Intra-Abdominal Irinotecan |
| Official title | Phase I Clinical and Pharmacokinetic Trial of Intra-Peritoneal Irinotecan |
| Lead sponsor | University of Southern California, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Adenocarcinoma, Gastric Cancer |
| Intervention type | Drug |
| Interventions | irinotecan |
| Enrollment | 42 |
| Start date | Sep 1, 1999 |
| Primary completion | Apr 1, 2009 |
| Completion | Apr 1, 2009 |
| First posted | Sep 16, 2005 |
| Last update posted | May 22, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: